ReportWire

Vivos Therapeutics GAAP EPS of -$1.04, revenue of $16.02M (NASDAQ:VVOS)

[ad_1]

Vivos Therapeutics GAAP EPS of -$1.04, revenue of $16.02M

[ad_2]

Source link